ANUHPHR Share Price Target 2028

CAGR-based price projection for Anuh Pharma Limited (ANUHPHR) targeting 2028, derived from official NSE exchange closing prices.

Bear Case (3.1% CAGR)
Rs 91
2028 Target
Base Case (7.6% CAGR)
Rs 99
2028 Target
Bull Case (20.6% CAGR)
Rs 125
2028 Target

Current Market Snapshot

CMP: Rs 85.85
52W High: Rs 96.74
52W Low: Rs 75.53
1Y CAGR: 15.9%
3Y CAGR: 7.6%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 88 Rs 92 Rs 104
2028 Rs 91 Rs 99 Rs 125

Other ANUHPHR Price Targets

2025 2026 2027 2030 2035 2040 2050

Frequently Asked Questions

What is the ANUHPHR share price target for 2028?

Based on historical growth analysis, the ANUHPHR share price target for 2028 ranges from Rs 91 (conservative) to Rs 99 (base case) to Rs 125 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of ANUHPHR?

The current market price of ANUHPHR (Anuh Pharma Limited) is Rs 85.85. The 52-week high is Rs 96.74 and 52-week low is Rs 75.53.

Is ANUHPHR a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for ANUHPHR price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 3.1% CAGR), Base (7.6% CAGR), and Bull (optimistic at 20.6% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.